Questions: Diabetic Ketoacidosis: Uncontrolled Lipolysis, Ketone Production, and Metabolic Acidosis

Question 1

A Type 1 diabetic patient in DKA has a serum potassium of 5.5 mEq/L (high-normal). A student concludes potassium replacement is unnecessary since levels are not low. What is the critical flaw in this reasoning?

• A. Serum potassium is irrelevant in DKA management — only glucose and pH matter initially
• B. Acidosis shifts potassium out of cells, making serum K⁺ falsely elevated; total body potassium is actually depleted, and insulin treatment will drive K⁺ back into cells precipitously
• C. The fruity breath indicates the patient is excreting potassium through the lungs, so supplementation is needed immediately for a different reason
• D. Potassium replacement is only needed after glucose has been fully corrected with insulin

Answer: (B)

In DKA, metabolic acidosis causes a transcellular shift of potassium out of cells into the bloodstream — serum K⁺ appears normal or elevated even though total body potassium is depleted from osmotic diuresis. When insulin is administered and drives K⁺ back into cells, serum levels can drop precipitously, causing life-threatening cardiac arrhythmias. Anticipating and managing this potassium shift is one of the most consequential decisions in DKA management.

Question 2

The central pathophysiological trigger for ketone body accumulation in DKA is:

• A. Excessive circulating glucose driving the liver to use ketogenesis as an overflow pathway
• B. Renal failure preventing clearance of ketones that are produced at a normal rate
• C. Uncontrolled lipolysis releasing free fatty acids that overwhelm the TCA cycle, channeling excess acetyl-CoA into ketogenesis
• D. The immune response triggering hepatic upregulation of ketone production as an emergency fuel

Answer: (C)

Without insulin to suppress hormone-sensitive lipase, adipose tissue releases massive amounts of free fatty acids. Under glucagon-dominant signaling, malonyl-CoA is suppressed and FFAs flood mitochondria via carnitine palmitoyl transferase I. Beta-oxidation generates more acetyl-CoA than the TCA cycle can process, so the overflow is converted to ketone bodies. High blood glucose is a concurrent problem but is not the trigger for ketogenesis.

Question 3

In DKA, Kussmaul breathing occurs because the kidneys fail to excrete CO₂, causing it to accumulate in the blood.

• T. True
• F. False

Answer: False

Kussmaul breathing is a respiratory compensation driven by the brain's respiratory center in response to metabolic acidosis. By increasing ventilation, the body blows off CO₂ — reducing carbonic acid in the blood and partially compensating for the acidosis caused by ketone accumulation. The kidneys are not the mechanism here; this is a pulmonary response to a metabolic problem.

Question 4

DKA can be understood as the body's starvation response (lipolysis, ketogenesis, gluconeogenesis) running without the insulin that would normally suppress it once glucose is available.

• T. True
• F. False

Answer: True

In starvation, counterregulatory hormones promote lipolysis and ketogenesis to fuel the brain with an alternative to glucose. Insulin normally terminates this response when glucose is available. In DKA, absolute or relative insulin deficiency removes this brake, so the catabolic starvation response runs unconstrained — paradoxically producing ketoacidosis in the context of hyperglycemia rather than hypoglycemia.

Question 5

Why is the treatment of DKA described as a 'controlled deceleration' rather than a rapid reversal of the metabolic cascade, and what specific risk does overly fast correction introduce?

Model answer: Rapid correction introduces two major risks: cerebral edema (especially in children), caused by osmotic shifts as hyperglycemia is reversed too quickly; and severe hypokalemia, as insulin drives potassium back into cells rapidly. If the total body potassium depletion is not anticipated and replaced, serum K⁺ can drop to arrhythmia-causing levels. The metabolic cascade must be decelerated in a monitored, controlled fashion rather than reversed all at once.

Each arm of the cascade (lipolysis, ketogenesis, osmotic diuresis, acidosis) must be addressed in coordination. Insulin stops the acid source but also triggers the potassium shift. Fluid resuscitation addresses hypovolemia but must be paced. The 'controlled deceleration' framing captures that even the correct treatments carry risks if applied too aggressively — the goal is a managed unwinding, not a reversal.